Dr. Hakim Bouterfa - Net Worth and Insider Trading

Dr. Hakim Bouterfa Net Worth

The estimated net worth of Dr. Hakim Bouterfa is at least $0 dollars as of 2025-07-02. Dr. Hakim Bouterfa is the Board of Directors of Eckert & Ziegler SE and owns about 0 shares of Eckert & Ziegler SE (XTER:EUZ) stock worth over $0. Details can be seen in Dr. Hakim Bouterfa's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dr. Hakim Bouterfa has not made any transactions after 2023-01-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Dr. Hakim Bouterfa

Dr. Hakim Bouterfa Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dr. Hakim Bouterfa owns 1 companies in total, including Eckert & Ziegler SE (XTER:EUZ) .

Click here to see the complete history of Dr. Hakim Bouterfa’s form 4 insider trades.

Insider Ownership Summary of Dr. Hakim Bouterfa

Ticker	Company	Transaction Date	Type of Owner
XTER:EUZ	Eckert & Ziegler SE	2023-01-11	Board of Directors

Dr. Hakim Bouterfa Latest Holdings Summary

Dr. Hakim Bouterfa currently owns a total of 1 stock. Dr. Hakim Bouterfa owns 0 shares of Eckert & Ziegler SE (XTER:EUZ) as of January 11, 2023, with a value of $0.

Latest Holdings of Dr. Hakim Bouterfa

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
XTER:EUZ	Eckert & Ziegler SE	2023-01-11	0	66.30	0

Holding Weightings of Dr. Hakim Bouterfa

Dr. Hakim Bouterfa Form 4 Trading Tracker

According to the SEC Form 4 filings, Dr. Hakim Bouterfa has made a total of 1 transactions in Eckert & Ziegler SE (XTER:EUZ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eckert & Ziegler SE is the acquisition of 2,600 shares on January 11, 2023, which cost Dr. Hakim Bouterfa around $124,800.

Insider Trading History of Dr. Hakim Bouterfa

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dr. Hakim Bouterfa Trading Performance

GuruFocus tracks the stock performance after each of Dr. Hakim Bouterfa's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dr. Hakim Bouterfa is -10.62%. GuruFocus also compares Dr. Hakim Bouterfa's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dr. Hakim Bouterfa within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Dr. Hakim Bouterfa's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Dr. Hakim Bouterfa

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	14.36
Relative Return to S&P 500(%)	11.32

Dr. Hakim Bouterfa Ownership Network

Ownership Network List of Dr. Hakim Bouterfa

No Data

Ownership Network Relation of Dr. Hakim Bouterfa

Dr. Hakim Bouterfa Owned Company Details

What does Eckert & Ziegler SE do?

Who are the key executives at Eckert & Ziegler SE?

Dr. Hakim Bouterfa is the Board of Directors of Eckert & Ziegler SE. Other key executives at Eckert & Ziegler SE include Supervisory Board Dr. Andreas Eckert , Supervisory Board Frank Perschmann , and Supervisory Board Prof. Dr. Wolfgang Maennig .

Eckert & Ziegler SE (XTER:EUZ) Insider Trades Summary

Over the past 18 months, Dr. Hakim Bouterfa made no insider transaction in Eckert & Ziegler SE (XTER:EUZ). Other recent insider transactions involving Eckert & Ziegler SE (XTER:EUZ) include a net sale of 0 shares made by Dr. Andreas Eckert ,

In summary, during the past 3 months, insiders sold 0 shares of Eckert & Ziegler SE (XTER:EUZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,720 shares of Eckert & Ziegler SE (XTER:EUZ) were sold and 6,720 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eckert & Ziegler SE (XTER:EUZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eckert & Ziegler SE Insider Transactions

No Available Data

Dr. Hakim Bouterfa Mailing Address

Above is the net worth, insider trading, and ownership report for Dr. Hakim Bouterfa. Currently GuruFocus does not have mailing address information for Dr. Hakim Bouterfa.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.